The second area of material impact on program spending is from the policies to allow ACOs to enter a new agreement period in the BASIC track when an ACO has fewer than 5,000 assigned beneficiaries in BY1, BY2, or both, in combination with capping the shared savings or shared losses at a lesser amount for ACOs with fewer than 5,000 assigned beneficiaries in any of the three benchmark years
Its effectiveness has also been demonstrated in insulin resistant conditions such as PCOS 3
These small gestures create trust that lasts far longer than any single win
Combination therapy also modestly improves weight, blood pressure, and lipid parameters, with reductions in body weight of approximately 11.5 kg versus SGLT2i alone, though evidence for additive effects on weight loss is inconsistent
The FDA has approved glutathione as an antioxidant, but not for skin-whitening purposes